VIDEO: Efficacy of DMTs decreases with age NORTH PARK – The efficacy of immunomodulatory disease-modifying therapies for multiple sclerosis decreases with age, and high-efficacy medicines execute a better job of inhibiting MS disability weighed against low-efficacy medications only in individuals more youthful than 40.5 years. Those will be the key conclusions from a meta-analysis from the age-dependent efficacy of MS remedies that was published in the November 2017 problem of Frontiers in Neurology. Inside a video interview, Ann Marie Weideman, business lead study author, talked about highlights in the meta-analysis on the conference held with the Americas Committee for Treatment and Analysis in Multiple Sclerosis.Prevents Alzheimer’s Disease 2. Lowers THREAT OF Heart Disease 3. Treats Depression 4. Encourages Healthy Bones 5. Improves Attention Health 6. Treats Arthritis 7. Lowers Tumor Risk 1. Prevents Alzheimer’s Disease Alzheimer’s is a degenerative mind disease which normally impacts people above age 60. This disease causes the speedy degeneration of human brain cells and network marketing leads to memory reduction, lack of coordination and stability from the physical body, depression, confusion, hostility, etc., which disease can’t be cured. A report released in The Journal Of American Medical Association in 2016, stated that eating fish frequently, improves the gray matter from the mind which prevents fast degeneration of mind cells and deterioration of mind functions during later years, thus avoiding Alzheimer’s disease.